Biomarker and Uses Thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jan 1, 2015
app pub date -
Jan 11, 2013
filing date -
Jan 13, 2012
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention provides a method of determining the prognosis of a subject with cancer, or determining the progression of a cancer, or of treating a cancer, wherein the method comprises the step of determining the expression level of PTPN9 in a cancer sample from the subject. Preferably a low level of expression of PTPN9, or no expression of PTPN9, is indicative of a poor prognosis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully